Combination of varlilumab and nivolumab

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Drug Information

Target Indication

Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Clinical Trial

Last updated: 9/24/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

BMY

Bristol-Myers Squibb Company

Related Pipeline

Hepatitis B

Bladder Cancer

Melanoma

Hepatitis C

Extensive-Stage Small Cell Lung Cancer

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts